MEX3A and bladder transitional cell carcinoma: MEX3A is known to be upregulated in Wilms renal cancer (Krepischi et al., 2016), gastric cancer (Jiang et al., 2012), bladder cancer (Huang et al., 2017) and bladder urothelial cancer (Shi & Huang, 2017).